Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Universal Genotyping in Tuberculosis Control Program, New York City, 2001–2003
  • Published Date:
    May 2006
  • Source:
    Emerg Infect Dis. 12(5):719-724.
  • Language:
    English
Filetype[PDF-128.65 KB]


Details:
No Related Documents.
You May Also Like:
  1. Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association. MMWR Recomm Rep 2020;69(No. RR-7).
    Personal Author:
    Cole B, Nilsen DM, Will L, et al.
    Published Date:
    07/31/2020
    Source:
    MMWR Recomm Rep 2020;69(No. RR-7)
    Series:
    MMWR Recommendations and Reports
    Description:
    SUPPLEMENTARY APPENDIX A: Responsibilities of the Tuberculosis Controller or Tuberculosis Program Manager; SUPPLEMENTARY APPENDIX B: Core Public Health Functions and Essential Services; SUPPLEMENTARY APPENDIX C: CDC-Funded Resources; SUPPLEMENTARY AP...
    File Type:
    Filetype[PDF - 698.42 KB]
  2. Operational considerations for infection prevention and control in outpatient facilities : non-U.S. healthcare settings
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 29, 2020
    Description:
    Updated July 29, 2020The Centers for Disease Control and Prevention (CDC) is working closely with international partners to respond to the coronavirus disease-2019 (COVID-19) pandemic. CDC provides technical assistance to help ther countries increase...
    File Type:
    Filetype[PDF - 130.03 KB]
  3. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections — New York City, March 2020
    Personal Author:
    Bushman, Dena; Alroy, Karen A.; Greene, Sharon K.; Keating, Page; Wahnich, Amanda; Weiss, Don; Pathela, Preeti; Harrison, Christy; Rakeman, Jennifer; Langley, Gayle; Tong, Suxiang; Tao, Ying; Uehara, Anna; Queen, Krista; Paden, Clinton R.; Szymczak, Wendy; Orner, Erika P.; Nori, Priya; Lai, Phi A.; Jacobson, Jessica L.; Singh, Harjot K.; Calfee, David P.; Westblade, Lars F.; Vasovic, Ljiljana V.; Rand, Jacob H.; Liu, Dakai; Singh, Vishnu; Burns, Janice; Prasad, Nishant; Sell, Jessica;
    Corporate Authors:
    CDC COVID-19 Surge Laboratory Group;
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):918-922
    Description:
    To limit introduction of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), the United States restricted travel from China on February 2, 2020, and from Europe on March 13. To determine whether local transmission of SARS-CoV-2 cou...
    File Type:
    Filetype[PDF - 241.46 KB]
  4. Symptom Profiles of a Convenience Sample of Patients with COVID-19 — United States, January–April 2020
    Personal Author:
    Burke, Rachel M.; Killerby, Marie E.; Newton, Suzanne; Ashworth, Candace E.; Berns, Abby L.; Brennan, Skyler; Bressler, Jonathan M.; Bye, Erica; Crawford, Richard; Harduar Morano, Laurel; Lewis, Nathaniel M.; Markus, Tiffanie M.; Read, Jennifer S.; Rissman, Tamara; Taylor, Joanne; Tate, Jacqueline E.; Midgley, Claire M.; Balachandran, Neha; Dahl, Rebecca M.; Dott, Mary; Gilani, Zunera; Grober, Aaron; Leung, Jessica; O’Hegarty, Michelle; Person, John; Ricaldi, Jessica N.; Roth, Nicole M.; Sejvar, James J.; Shimabukuro, Tom; Tran, Cuc H.; Watson, John T.; Whitham, Hilary; Chiou, Howard; Clogher, Paula; Duca, Lindsey M.; Dratch, Alissa; Feldpausch, Amanda; Fill, Mary-Margaret; Ghinai, Isaac; Holshue, Michelle; Scott, Sarah; Westergaard, Ryan;
    Corporate Authors:
    Case Investigation Form Working Group. Case Investigation Form Working Group. Case Investigation Form Working Group.
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):904-908
    Description:
    Coronavirus disease 2019 (COVID-19) was first detected in the United States in January 2020 (1), and by mid-July, approximately 3.4 million cases had been reported in the United States (2). Information about symptoms among U.S. COVID-19 patients is l...
    File Type:
    Filetype[PDF - 194.46 KB]
  5. Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
    Personal Author:
    Ko, Jean Y.; D’Angelo, Denise V.; Haight, Sarah C.; Morrow, Brian; Cox, Shanna; Salvesen von Essen, Beatriz; Strahan, Andrea E.; Harrison, Leslie; Tevendale, Heather D.; Warner, Lee; Kroelinger, Charlan D.; Barfield, Wanda D.;
    Published Date:
    July 17 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(28):897-903
    Description:
    Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%-22% of women filled a prescription for opioids during pregnancy; however, data on self-...
    File Type:
    Filetype[PDF - 335.25 KB]